National Veterinary Care Ltd rises 7.5% to an all-time high

National Veterinary Care Ltd (ASX: NVL) rose by 7.53% today and 4.29% yesterday. The share price has more than doubled since it listed in August 2015 and I think it could go on to grow into a sizeable business.

The business has been on a steady acquisition spree since it first listed and recently announced that it will be acquiring four more clinics that will add $4.5 million of revenue and $0.79 million of earnings before interest and tax over a 12 month period. Management expect that these clinics will be earnings per share (EPS) accretive in FY18.

The pet industry is a good one to operate in with a growing pet population, humanisation of pets and increased take-up of pet insurance. Around three quarters of dogs and two thirds of cats go to a vet each year. All of these factors were major reasons why general practice organic growth was 4.2% in FY17.

The wellness program called ‘best for pet’ has been very successful for National Vet Care. It now has around 14,000 members which represents growth of about 30% since 1 July 2017. Members’ average spend reportedly increases by 94% after joining the program.

National Vet Care reported that it generated 8.46 cents basic EPS and 11.38 cents underlying EPS in FY17. The difference between these two figures is the acquisition and other one-off costs. This suggests that with no other acquisitions in FY18 it would have shown growth EPS growth of around 34%.

However, management have predicted that statutory revenue will likely grow by at least 25% in FY18, which means that FY18 could be another bumper year for the company.

Foolish takeaway

National Vet Care is currently trading at 28x FY17’s underlying earnings, which I think is a reasonable price to pay for a business that may grow at a strong rate over the next few years.

Other shares I’m confident will have a good 2018 are these growth shares.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of NATVETCARE FPO. The Motley Fool Australia owns shares of NATVETCARE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!